Yamamuro, Tadashi http://orcid.org/0000-0002-0610-5204
Kawabata, Tsuyoshi
Fukuhara, Atsunori http://orcid.org/0000-0002-6289-3778
Saita, Shotaro
Nakamura, Shuhei http://orcid.org/0000-0002-1488-8317
Takeshita, Hikari
Fujiwara, Mari
Enokidani, Yusuke
Yoshida, Gota
Tabata, Keisuke http://orcid.org/0000-0001-6776-1689
Hamasaki, Maho
Kuma, Akiko
Yamamoto, Koichi
Shimomura, Iichiro
Yoshimori, Tamotsu
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP18gm5010001 and JP17gm0610005)
MEXT | Japan Society for the Promotion of Science
Takeda Science Foundation
Human Frontier Science Program
A3 Foresight Program
Article History
Received: 18 October 2018
Accepted: 28 July 2020
First Online: 18 August 2020
Competing interests
: I.S. and T.Yo. have applied for the patent related to this work. T.Yo. is the founder for AutoPhagyGO. A.F. belongs to the department endowed by Takeda Pharmaceutical Company, Rohto Pharmaceutical Co., Ltd, Sanwa Kagaku Kenkyusho Co., Ltd, Fuji Oil Holdings Inc. and Kobayashi Pharmaceutical Co., Ltd. All other authors declare no competing interests.